Novartis
NVS
NVS
1,221 hedge funds and large institutions have $15.1B invested in Novartis in 2023 Q3 according to their latest regulatory filings, with 96 funds opening new positions, 374 increasing their positions, 448 reducing their positions, and 60 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,221
Holders Change
+21
Holders Change %
+1.75%
% of All Funds
19.47%
Holding in Top 10
16
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+23.08%
% of All Funds
0.26%
New
96
Increased
374
Reduced
448
Closed
60
Calls
$253M
Puts
$270M
Net Calls
-$16.3M
Net Calls Change
-$401M
Top Buyers
Top Sellers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
$18.5M |
| 2 |
Primecap Management
Pasadena,
California
|
$1.49B |
| 3 |
Twin Tree Management
Dallas,
Texas
|
$1.55M |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
$20.8M |
| 5 |
Morgan Stanley
New York
|
$711M |
